Downstream Issues Still Beset Production
To Protect the Bottom Line, Biomanufacturers Invest in Downstream Purification Technology
GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
10 Takeover Targets of 2016
Which Biopharmas Do Wall Street Watchers View As Top Buyout Candidates?
- STEMCELL Technologies
- 570 West Seventh Avenue
- Suite 400
- Vancouver BC, V5Z 1B3
STEMCELL Technologies is a privately-owned biotechnology company that develops specialty cell culture media, cell separation products and ancillary reagents for life science research. STEMCELL delivers over 1500 products to more than 70 countries worldwide.